CRESEMBA is indicated in adults for the treatment of: invasive aspergillosis; mucormycosis in patients for whom amphotericin B is inappropriate (see Precautions and Pharmacology: Pharmacodynamics under Actions).
Consideration should be given to official guidance on the appropriate use of antifungal agents.